Sanofi and McLaren Racing have entered into a multiyear partnership aimed at improving Sanofi’s manufacturing practices.

McLaren will share with the drugmaker what it has learned in its “Accelerator” program, such as the use of modeling and simulation of production-line scheduling and product changeovers.

The new collaboration follows a pilot program that began in 2021. The goal is to maximize Sanofi’s performance at multiple manufacturing sites in seven countries.

This is not the first time the Formula 1 racing company has teamed up with a drugmaker; McLaren previously worked with GlaxoSmithKline in 2011, helping to improve that company’s manufacturing practices.